Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 37Squamous Cell Carcinoma of Head and Neck 19Head and Neck Neoplasms 17Nasopharyngeal Neoplasms 7Salivary Gland Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Pancreatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Recurrence 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Neoplasms 3Esthesioneuroblastoma, Olfactory 3Esophageal Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Ovarian Neoplasms 2Neoplasm Metastasis 2Hypopharyngeal Neoplasms 2Gallbladder Neoplasms 2Bile Duct Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Spinocerebellar Degenerations 1Skin Neoplasms 1Neoplasms, Unknown Primary 1

Interventions

spartalizumab 1Oxaliplatin 1Nivolumab 1Leucovorin 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spinocerebellar Degenerations × Capecitabine × Head & Neck × Clear all
NCT06544655 2026-04-17

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

Phase 1 Active not recruiting
213 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡